A case for real-time clinical pharmacology analysis in drug development. AI & ML are rapidly changing how we perform clinical trial analysis and identify optimal dosing strategies for new drugs. Unified platforms coupled with integrated data are making real-time clinical pharmacology analysis a reality. Lifescience organizations are harnessing these new capabilities to create an automated repeatable analysis process, removing redundant/manual steps and accelerating the overall dose identification process.
Brought to you by:
This session is sponsored by an ASCPT Partner organization. The content of the session is provided for informational purposes only and does not constitute or imply ASCPT’s endorsement, recommendation, or approval of a specific institution, service, or speaker.
